Tuesday 20 August 2019

Dr Reddy's Launches Vigabatrin Oral Powder In US Market

Dr Reddy's launches Vigabatrin oral powder in US market: The company launched Vigabatrin Powder for oral solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril powder for oral solution, USP, approved by the US Food and Drug Administration.

Shares of Kwality touched 52-week low of Rs 2.19, down 4.3 percent on August 20 as company's losses widened in the quarter ended June 2019. The company's Q1FY20 loss was at Rs 64.6 crore against loss of Rs 0.85 crore in a year ago period.


For more information +91- 6232578593 or visit www.moneymarketmanthan.com

No comments:

Post a Comment

Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India

Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...